Comparative study between the therapeutic effect of Remdesivir versus Hydroxychloroquine in Covid-19 hospitalized patients.
Microbes and Infectious Diseases, doi:10.21608/mid.2021.85877.1177
announced infections and about 4000 deaths were reported in more than 100 countries [1, 2] . In Egypt, the officially reported COVID-19 confirmed cases were 94,316 with 4,834 deaths on August 2020  .
Conflict of interest: no conflict of interest.
Authors' Contribution All authors contributed equally to this work.
Financial disclosure This study was done as a part of the outbreak investigation conducted at Tanta University Hospitals, Egypt and supported by the Ministry of Higher Education (MHE). Patients with laboratory-confirmed SARS-CoV-2 infection, who were admitted to Tanta University Isolation Hospital ICU between June and September, 2020 were included.
-Ali, Ali, Ahmed, Wy, Characteristics, and predictive factors of disease severity in hospitalized patients with SARS-COV-2 in Fayoum governorate, Egypt: a multicenter study, Microbes and Infectious Diseases
-Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, Jama
-Yang, Islam, Wang, Li, Chen, Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective, International journal of biological sciences
Abena, Decloedt, Bottieau, Suleman, Adejumo et al., Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: caution for inappropriate off-label use in healthcare settings, The American journal of tropical medicine and hygiene
Corman, Landt, Kaiser, Molenkamp, Meijer et al., Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, Eurosurveillance
Devaux, Rolain, Colson, Raoult, None
Nas, Ali, Azu, Abdallah, Yusuf, Epidemiology of novel COVID-19 in Nigeria, Microbes and Infectious Diseases